🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05990946
Recruiting Not applicable

Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer

NCT05990946 · tracked via the Priya Life Science China tracker
Sponsor
Zhongshan People's Hospital, Guangdong, China
Phase
Not applicable
Started
2023-12-01
Last updated
2026-09-04

Condition(s) studied

Lung Neoplasms, Non-Small Cell Lung CancerPostoperative ComplicationsPatient Reported Outcome MeasuresTelerehabilitationExercise Therapy

Investigational drug(s) / intervention(s)

ePRO based Remote Symptom Management provide by a mobile phone app

ePRO based Remote Symptom Management provide by a mobile phone app: Alerts are triggered if any of 5 core symptoms scored ≥4, prompting remote clinician feedback and guidance on symptom management. This is facilitated through the "Shuyu" mobile application, which serves as the platform for monitoring symptoms and communication.

Study summary

Brief Summary: This randomized controlled trial aims to evaluate whether active remote symptom monitoring and management via a smartphone app utilizing electronic patient-reported outcomes (ePRO) can improve adherence to prescribed outpatient pulmonary rehabilitation exercises among postsurgical lung cancer patients. Eligible patients will use the app for perioperative care and be randomized to an intervention group receiving ePRO-based symptom monitoring with clinician feedback or a control group receiving ePRO without feedback. The primary outcome is rehabilitation exercise adherence rate over 1 month after discharge. If proven effective, the app-enabled remote rehabilitation model can be scaled up to enhance recovery for more postoperative patients.

Due to slower-than-expected recruitment, an interim analysis was introduced through a protocol amendment. Before any unblinded between-group efficacy analysis, a blinded review of recruitment progress, data completeness, and outcome-data structure was conducted. Mean weekly exercise duration was subsequently added as a co-primary endpoint to complement the threshold-based exercise adherence outcome. The amendment and revised interim statistical framework were approved by the Ethics Committee before the formal interim analysis and incorporated into the updated study record.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Age 18-75 years old * preoperative clinical diagnosis or suspicion of resectable primary lung cancer * Able to use smartphones and complete electronic questionnaires * Signed informed consent Exclusion Criteria: * conversions to open thoracotomy during surgery * ECOG score \> 1 * Received neoadjuvant therapy * Previous lung resection surgery * Unable to exercise due to physical limitations * Continuous systemic corticosteroid use within 1 month before enrollment * Unresolved toxicity above Grade 1 from previous treatments * Significant comorbidities or medical history

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
No.2 Sunwen East Rd. Zhongshan Guangdong Recruiting

More Zhongshan People's Hospital, Guangdong, China trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05990946 on ClinicalTrials.gov ↗ ← All trials in China